- Home
- ITOS vs VKI Comparison
ITOS vs VKI Comparison
Compare ITOS & VKI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITOS
- VKI
- Stock Information
- Founded
- ITOS 2011
- VKI 1993
- Country
- ITOS United States
- VKI United States
- Employees
- ITOS N/A
- VKI N/A
- Industry
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- VKI Finance Companies
- Sector
- ITOS Health Care
- VKI Finance
- Exchange
- ITOS Nasdaq
- VKI Nasdaq
- Market Cap
- ITOS 381.2M
- VKI 377.0M
- IPO Year
- ITOS 2020
- VKI N/A
- Fundamental
- Price
- ITOS $10.17
- VKI $8.20
- Analyst Decision
- ITOS Hold
- VKI
- Analyst Count
- ITOS 6
- VKI 0
- Target Price
- ITOS $10.60
- VKI N/A
- AVG Volume (30 Days)
- ITOS 1.5M
- VKI 112.8K
- Earning Date
- ITOS 08-07-2025
- VKI 01-01-0001
- Dividend Yield
- ITOS N/A
- VKI 4.52%
- EPS Growth
- ITOS N/A
- VKI N/A
- EPS
- ITOS N/A
- VKI N/A
- Revenue
- ITOS $35,000,000.00
- VKI N/A
- Revenue This Year
- ITOS N/A
- VKI N/A
- Revenue Next Year
- ITOS N/A
- VKI N/A
- P/E Ratio
- ITOS N/A
- VKI N/A
- Revenue Growth
- ITOS 177.89
- VKI N/A
- 52 Week Low
- ITOS $4.80
- VKI $7.07
- 52 Week High
- ITOS $18.13
- VKI $8.98
- Technical
- Relative Strength Index (RSI)
- ITOS 58.43
- VKI 43.76
- Support Level
- ITOS $10.10
- VKI $8.14
- Resistance Level
- ITOS $10.47
- VKI $8.24
- Average True Range (ATR)
- ITOS 0.12
- VKI 0.07
- MACD
- ITOS -0.06
- VKI -0.02
- Stochastic Oscillator
- ITOS 23.08
- VKI 19.83
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.
About VKI Invesco Advantage Municipal Income Trust II of Beneficial Interest (DE)
Invesco Advantage Municipal Income Trust II is a diversified, closed-end management investment company. The investment objective of the company is to provide common shareholders with a high level of current income exempt from federal income tax, consistent with preservation of capital.